TRB Chemedica International SA

trbchemedica.com

TRB Chemedica is a medium-sized Swiss pharmaceutical company, with a focus on research, development and marketing of innovative niche products in specific therapeutic areas, including rheumatology, ophthalmology and neurology.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharmacy Market

IA COMMEMORATES 50 YEARS OF INNOVATION WITH LAUNCH OF NEW PHARMACY SOLUTIONS AT NACDS TOTAL STORE EXPO

iA | August 26, 2022

news image

iA, a leading provider of pharmacy fulfillment and automation solutions, is celebrating 50 years of innovation at NACDS Total Store Expo. With a commitment to its heritage, iA’s mission has never wavered from streamlining operational processes through advancing technology. Today, iA continues to drive pharmacy industry innovations. From safe and accurate filling of prescriptions through the use of modern robotics, to production control software enhanced by warehouse manageme...

Read More

Business Insights

TFF PHARMACEUTICALS EXPANDS R&D OPERATIONS WITH NEW AUSTIN FACILITY

TFF Pharmaceuticals, Inc. | July 16, 2022

news image

TFF Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced a significant expansion of its R&D operations through the lease of a new research and development facility located in Austin, Texas. The new facility of over 3,500 square feet significantly increases TFF’s total lab space, adding a dedicated lab for downs...

Read More

PFIZER CONTINUES RECALLS OF MENOPAUSE DRUG DUAVEE ON FAULTY PACKAGING CONCERNS

Fiercepharma | June 09, 2020

news image

Consumers are on edge as the COVID-19 pandemic casts doubts on the quality of drugs reaching shelves around the world. On U.S. shores, experts say those issues are warranted—and a wave of Pfizer recalls for menopause drug Duavee won't help build confidence. Pfizer voluntarily recalled two batches of Duavee––marketed as Duavive abroad––from U.K. shelves after identifying faulty packaging that may have reduced the drug's efficacy, the U.K.'s Medicines and ...

Read More

Business Insights

LOVE PHARMAS INVESTMENT IN US BIOTECH OFFERS STRATEGIC INDUSTRY ADVANTAGES AND ENHANCED SHAREHOLDER VALUE

LOVE Pharma | September 09, 2022

news image

Love Pharma Inc. an international mental health and sexual wellness company, remains extremely active in shaping itself into a real competitor in the biotech/pharmaceutical space. The company’s growth and development plan took a major leap forward this week with the announcement that Love Pharma is establishing a “strategic alliance” with Starton Therapeutics a leading clinical-stage biotechnology company in the United States. It’s a relationship that...

Read More
news image

Pharmacy Market

IA COMMEMORATES 50 YEARS OF INNOVATION WITH LAUNCH OF NEW PHARMACY SOLUTIONS AT NACDS TOTAL STORE EXPO

iA | August 26, 2022

iA, a leading provider of pharmacy fulfillment and automation solutions, is celebrating 50 years of innovation at NACDS Total Store Expo. With a commitment to its heritage, iA’s mission has never wavered from streamlining operational processes through advancing technology. Today, iA continues to drive pharmacy industry innovations. From safe and accurate filling of prescriptions through the use of modern robotics, to production control software enhanced by warehouse manageme...

Read More
news image

Business Insights

TFF PHARMACEUTICALS EXPANDS R&D OPERATIONS WITH NEW AUSTIN FACILITY

TFF Pharmaceuticals, Inc. | July 16, 2022

TFF Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced a significant expansion of its R&D operations through the lease of a new research and development facility located in Austin, Texas. The new facility of over 3,500 square feet significantly increases TFF’s total lab space, adding a dedicated lab for downs...

Read More
news image

PFIZER CONTINUES RECALLS OF MENOPAUSE DRUG DUAVEE ON FAULTY PACKAGING CONCERNS

Fiercepharma | June 09, 2020

Consumers are on edge as the COVID-19 pandemic casts doubts on the quality of drugs reaching shelves around the world. On U.S. shores, experts say those issues are warranted—and a wave of Pfizer recalls for menopause drug Duavee won't help build confidence. Pfizer voluntarily recalled two batches of Duavee––marketed as Duavive abroad––from U.K. shelves after identifying faulty packaging that may have reduced the drug's efficacy, the U.K.'s Medicines and ...

Read More
news image

Business Insights

LOVE PHARMAS INVESTMENT IN US BIOTECH OFFERS STRATEGIC INDUSTRY ADVANTAGES AND ENHANCED SHAREHOLDER VALUE

LOVE Pharma | September 09, 2022

Love Pharma Inc. an international mental health and sexual wellness company, remains extremely active in shaping itself into a real competitor in the biotech/pharmaceutical space. The company’s growth and development plan took a major leap forward this week with the announcement that Love Pharma is establishing a “strategic alliance” with Starton Therapeutics a leading clinical-stage biotechnology company in the United States. It’s a relationship that...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us